Insider Trading History of Ball Kristine M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Ball Kristine M since 2015. The trader's CIK number is 1266163. At the time of the last reporting, Ball Kristine M was the Chief Financial Officer & SVP of Menlo Therapeutics Inc.. (stock ticker symbol MNLO). Also see all insider trading activities at Menlo Therapeutics Inc..

Note that in the past BALL KRISTINE M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Relypsa Inc (RLYP) by Ball Kristine M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 RLYP 7,000 $85,050 0 $0 0 $0
2015 RLYP 0 $0 7,875 $283,566 6,000 $23,760

Yearly summary of insider trading at Menlo Therapeutics Inc. (MNLO) by Ball Kristine M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MNLO 0 $0 0 $0 80,300 $0


Insider trading activities at 2 companies by Ball Kristine M:

1. Relypsa Inc (RLYP)

2. Menlo Therapeutics Inc. (MNLO)

Table 1. Insider trading of Relypsa Inc (RLYP) by Ball Kristine M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-16 RLYP Buy 7,000 12.15 85,050
2015-09-02 RLYP Sale 646 22.96 14,832
2015-08-17 RLYP Sale 710 24.79 17,597
2015-03-05 RLYP Sale 3,000 41.00 123,000
2015-03-05 RLYP Option Ex 3,000 3.96 11,880
2015-03-03 RLYP Sale 519 38.80 20,137
2015-01-21 RLYP Sale 3,000 36.00 108,000
2015-01-21 RLYP Option Ex 3,000 3.96 11,880

Table 2. Insider trading of Menlo Therapeutics Inc. (MNLO) by Ball Kristine M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-11 MNLO Option Ex 80,300 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ball Kristine M (Chief Financial Officer & SVP of Menlo Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.